Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Evaluation of efficacy and safety of GSK5764227 (alone and in combination) in participants with previously treated advanced unresectable or … Recruiting

2025-520672-26-00 Gastrointestinal Neoplasms 9 2025-09-16
A phase 2 study of the effectiveness of golcadomide (CC-99282) for patients with large B-cell lymphoma in the brain Recruiting

2024-517051-12-00 Relapsed primary large B-cel lymphoma of the central ne 4 2025-09-16
Hormonal Receptor (HR)-positive HER2 negative breast cancer patients treated with preoperative ELacestrant and PULSAR adaptive radiotherapy:… Recruiting

2025-520762-22-00 Patients with HR-positive, HER2-negative, non-metastati 4 2025-09-16
A Study of Navlimetostat (BMS986504) in Participants with Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer with Homozygous MTAP… Recruiting

2024-519814-29-00 Advanced or Metastatic Non-small Cell Lung Cancer 4 2025-09-12
Study of Trastuzumab Deruxtecan with Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer… Recruiting

2024-516982-35-00 Ovarian Cancer 5 2025-09-11
Optimizing endocrine treatment > 5 years after surgery for breast cancer patients: a registry-based randomized clinical trial Recruiting

2023-506135-14-00 Breast cancer 11 2025-09-10
Study to evaluate the efficacy and safety of [177Lu]Lu-DOTA-TATE in patients with Grade 1 and Grade 2 advanced GEP-NET (NETTER-3) Recruiting

2024-518325-15-00 Gastroenteropancreatic neuroendocrine tumor (GEP-NET) 5 2025-09-08
Phase I/IIa clinical trial with dose escalation to evaluate safety and efficacy of the infusion of CART84 in relapsed/refractory (R/R) acute… Recruiting

2024-519966-31-00 Relapsed/refractory Acute Lymphoblastic T Leukemia (T-A 7 2025-09-08
Single Arm Study of WSD0922-FU for NSCLC Patients with C797S mutation Recruiting

2024-519713-65-00 Non-Small Cell Lung Cancer 4 2025-09-04
ALBU-CHIP - Efficacy of human 20% albumin solution + Ringer Lactate versus Ringer Lactate for fluid replacement strategy during cytoreductiv… Recruiting

2024-510943-76-00 Cytoreductive surgery with hyperthermic intraperitoneal 5 2025-09-03
A clinical study of ifinatamab deruxtecan and pembrolizumab with or without chemotherapy in people with esophageal cancer (MK-3475-06E) Recruiting

2024-514273-22-00 Esophageal squamous cell carcinoma 9 2025-09-02
Effect of methylphenidate on cancer-related fatigue in patients treated for a brain tumor during childhood or adolescence: Protocol for a ra… Recruiting

2023-507926-18-00 Cancer-related fatigue after treatment of pediatric bra 5 2025-09-02
PANCEP-1 Recruiting

2023-506979-10-00 Pancreatic cancer 9 2025-09-02
A clinical study of MK-5684 in people with certain solid tumors (MK-5684-015) Recruiting

2024-519563-18-00 Breast cancer, Ovarian cancer, Endometrial cancer 10 2025-09-02
[18F]Tetrafluoroborate PET/CT for the Detection of Differentiated Thyroid Cancer: A Phase II Imaging Study Recruiting

2024-516025-30-00 Differentiated Thyroid Cancer 4 2025-09-01
18F-FDG versus 68Ga-FAPI-46 as PET tracer in ER-positive breast cancer - a pilot study Recruiting

2023-508066-15-01 Hormone-positive breast cancer 4 2025-09-01
PSEUDOVAX – A CANCER VACCINE TARGETING MUTATED GNAS COMBINED WITH IMMUNE CHECKPOINT INHIBITION FOR PATIENTS WITH PSEUDOMYXOMA PERITONEI Recruiting

2024-517047-30-01 Pseudomyxoma Peritonei 1 2025-09-01
Long-term follow-up of patients previously treated with autologous T cells genetically modified with viral vectors. Recruiting

2024-511684-28-00 Potential malignancy in patients who received treatment 4 2025-09-01
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic… Recruiting

2024-516772-15-00 Prostate Cancer 1 2025-08-29
A Phase 2 study of JNJ-90301900 with chemoradiation and durvalumab for non-small cell lung cancer Recruiting

2024-518276-32-00 Locally advanced and unresectable Stage III non-small c 4 2025-08-29
A clinical study of combination therapies in people with kidney cancer (MK-3475-03C) Recruiting

2024-516437-12-00 Clear cell renal cell carcinoma 9 2025-08-29
A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma Recruiting

2024-514635-26-00 Hepatoblastoma and liver cancer (hepatocarcinoma) 5 2025-08-28
Study of Daraxonrasib (RMC-6236) in Patients with RAS Mutated NSCLC Recruiting

2024-518154-16-00 non-small cell lung cancer 5 2025-08-27
A clinical study of treatments for non-small cell lung cancer (MK-3475-01H) Recruiting

2024-518761-10-00 Non-small Cell Lung Cancer 4 2025-08-25